{"pmid":32359194,"title":"COVID-19 In Spain: Transplantation In The Midst Of The Pandemic.","text":["COVID-19 In Spain: Transplantation In The Midst Of The Pandemic.","Spain has been one of the most affected countries by the COVID-19 outbreak. As of 28 April 2020, the number of confirmed cases is 210,773, including 102,548 patients recovered, more than 10,300 admitted to the ICU, and 23,822 deaths, with a global case fatality rate of 11.3%. From the perspective of donation and transplantation, the Spanish system first focused on safety issues, providing recommendations for donor evaluation and testing, and to rule out SARS-CoV-2 infection in potential recipients prior to transplantation. Since the country entered into an epidemiological scenario of sustained community transmission and saturation of intensive care, developing donation and transplantation procedures has become highly complex. Since the national state of alarm was declared in Spain on 13 March 2020, the mean number of donors has declined from 7.2 to 1.2 per day, and the mean number of transplants from 16.1 to 2.1 per day. Increased mortality on the waiting list may become a collateral damage of this terrible pandemic.","Am J Transplant","Dominguez-Gil, Beatriz","Coll, Elisabeth","Fernandez-Ruiz, Mario","Corral, Esther","Del Rio, Francisco","Zaragoza, Rafael","Rubio, Juan Jose","Hernandez, Domingo","32359194"],"abstract":["Spain has been one of the most affected countries by the COVID-19 outbreak. As of 28 April 2020, the number of confirmed cases is 210,773, including 102,548 patients recovered, more than 10,300 admitted to the ICU, and 23,822 deaths, with a global case fatality rate of 11.3%. From the perspective of donation and transplantation, the Spanish system first focused on safety issues, providing recommendations for donor evaluation and testing, and to rule out SARS-CoV-2 infection in potential recipients prior to transplantation. Since the country entered into an epidemiological scenario of sustained community transmission and saturation of intensive care, developing donation and transplantation procedures has become highly complex. Since the national state of alarm was declared in Spain on 13 March 2020, the mean number of donors has declined from 7.2 to 1.2 per day, and the mean number of transplants from 16.1 to 2.1 per day. Increased mortality on the waiting list may become a collateral damage of this terrible pandemic."],"journal":"Am J Transplant","authors":["Dominguez-Gil, Beatriz","Coll, Elisabeth","Fernandez-Ruiz, Mario","Corral, Esther","Del Rio, Francisco","Zaragoza, Rafael","Rubio, Juan Jose","Hernandez, Domingo"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32359194","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/ajt.15983","locations":["Spain","Spanish","Spain","Spain"],"countries":["Spain"],"countries_codes":["ESP|Spain"],"topics":["Prevention"],"weight":1,"_version_":1666138495324782592,"score":9.490897,"similar":[{"pmid":32243677,"title":"The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs.","text":["The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs.","The spread of Coronavirus Disease 2019 (COVID-19) has already reached a pandemic dimension within a few weeks. Italy has been one of the first countries dealing with the outbreak of COVID-19, and severe measures have been adopted to limit viral transmission. The spread of COVID-19 may have several implications in organ transplant activity that physicians should be aware of. The initial experience gained during the COVID-19 outbreak shows that around 10% of infected patients in Italy need intensive care management to overcome the acute respiratory distress syndrome. Due to the exponential rise of infected patients we are now facing an actual risk of saturation of intensive care unit (ICU) beds. A restriction in the number of ICU beds available for both donors and transplant recipients may unfavorably influence the overall donation activity, and eventually lead to a reduced number of transplants. Preliminary Italian data show that a 25% reduction of procured organs has already occurred during the first 4 weeks of COVID-19 outbreak. This underlines the need to closely monitor what will be further happening in ICUs due to the COVID-19 spread in the attempt to preserve transplant activity, especially in Western countries where deceased donors represent the major organ resource.","Am J Transplant","Angelico, Roberta","Trapani, Silvia","Manzia, Tommaso Maria","Lombardini, Letizia","Tisone, Giuseppe","Cardillo, Massimo","32243677"],"abstract":["The spread of Coronavirus Disease 2019 (COVID-19) has already reached a pandemic dimension within a few weeks. Italy has been one of the first countries dealing with the outbreak of COVID-19, and severe measures have been adopted to limit viral transmission. The spread of COVID-19 may have several implications in organ transplant activity that physicians should be aware of. The initial experience gained during the COVID-19 outbreak shows that around 10% of infected patients in Italy need intensive care management to overcome the acute respiratory distress syndrome. Due to the exponential rise of infected patients we are now facing an actual risk of saturation of intensive care unit (ICU) beds. A restriction in the number of ICU beds available for both donors and transplant recipients may unfavorably influence the overall donation activity, and eventually lead to a reduced number of transplants. Preliminary Italian data show that a 25% reduction of procured organs has already occurred during the first 4 weeks of COVID-19 outbreak. This underlines the need to closely monitor what will be further happening in ICUs due to the COVID-19 spread in the attempt to preserve transplant activity, especially in Western countries where deceased donors represent the major organ resource."],"journal":"Am J Transplant","authors":["Angelico, Roberta","Trapani, Silvia","Manzia, Tommaso Maria","Lombardini, Letizia","Tisone, Giuseppe","Cardillo, Massimo"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243677","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15904","keywords":["critical care/intensive care management","donors and donation: donor-derived infections","editorial/personal viewpoint","epidemiology","health services and outcomes research","infection and infectious agents - viral","infectious disease","organ procurement and allocation","organ procurement organization","organ transplantation in general"],"locations":["Italy","Italy","Italian","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138492107751424,"score":306.51135},{"pmid":32330351,"title":"The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy.","text":["The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy.","In January 2020, Novel Coronavirus Disease 2019 (COVID-19) resulted in a global pandemic, creating uncertainty towards the management of Liver Transplantation (LT) programmes. Lombardy has been the most affected region in Italy: The current mortality rate of COVID-19 patients is 18,3% (10022 deaths) (April 10th) with hospitals in Lombardy having to expand the total number of ICU beds from 724 to 1381 to accommodate infected patients. There has been a drastic decrease in liver donors. From February 23(rd) until April 10th, 17 LTs were performed in Lombardy. Mean donor age was 49 years (range 18-74) whereas mean recipient age was 55 (13-69); mean MELD Score was 12 (6-24). All donors underwent screening for SARS CoV-2 prior to LT. Two patients tested positive after LT, and one patient died for COVID on POD 30. 16 patients are alive after an average of 30 days post LT (range 3-46). 10 patients have been discharged. This study has found no specific reason concerning the safety of recipients, to stop liver transplantation programmes. Several Key-lessons from our experience are reported. However, due to the complex circumstances which surround the viral outbreak, the cessation or a reduction in LT activity is a pragmatic requirement.","Am J Transplant","Maggi, Umberto","De Carlis, Luciano","Yiu, Daniel","Colledan, Michele","Regalia, Enrico","Rossi, Giorgio","Angrisani, Marco","Consonni, Dario","Fornoni, Gianluca","Piccolo, Giuseppe","DeFeo, Tullia Maria","32330351"],"abstract":["In January 2020, Novel Coronavirus Disease 2019 (COVID-19) resulted in a global pandemic, creating uncertainty towards the management of Liver Transplantation (LT) programmes. Lombardy has been the most affected region in Italy: The current mortality rate of COVID-19 patients is 18,3% (10022 deaths) (April 10th) with hospitals in Lombardy having to expand the total number of ICU beds from 724 to 1381 to accommodate infected patients. There has been a drastic decrease in liver donors. From February 23(rd) until April 10th, 17 LTs were performed in Lombardy. Mean donor age was 49 years (range 18-74) whereas mean recipient age was 55 (13-69); mean MELD Score was 12 (6-24). All donors underwent screening for SARS CoV-2 prior to LT. Two patients tested positive after LT, and one patient died for COVID on POD 30. 16 patients are alive after an average of 30 days post LT (range 3-46). 10 patients have been discharged. This study has found no specific reason concerning the safety of recipients, to stop liver transplantation programmes. Several Key-lessons from our experience are reported. However, due to the complex circumstances which surround the viral outbreak, the cessation or a reduction in LT activity is a pragmatic requirement."],"journal":"Am J Transplant","authors":["Maggi, Umberto","De Carlis, Luciano","Yiu, Daniel","Colledan, Michele","Regalia, Enrico","Rossi, Giorgio","Angrisani, Marco","Consonni, Dario","Fornoni, Gianluca","Piccolo, Giuseppe","DeFeo, Tullia Maria"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330351","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ajt.15948","locations":["Italy","Lombardy","Lombardy","Score"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138494578196481,"score":289.67038},{"pmid":32371150,"title":"Immediate impact of COVID-19 on transplant activity in the Netherlands.","text":["Immediate impact of COVID-19 on transplant activity in the Netherlands.","The rapid emergence of the COVID-19 pandemic is unprecedented and poses an unparalleled obstacle in the sixty-five year history of organ transplantation. Worldwide, the delivery of transplant care is severely challenged by matters concerning - but not limited to - organ procurement, risk of SARS-CoV-2 transmission, screening strategies of donors and recipients, decisions to postpone or proceed with transplantation, the attributable risk of immunosuppression for COVID-19 and entrenched health care resources and capacity. The transplant community is faced with choosing a lesser of two evils: initiating immunosuppression and potentially accepting detrimental outcome when transplant recipients develop COVID-19 versus postponing transplantation and accepting associated waitlist mortality. Notably, prioritization of health care services for COVID-19 care raises concerns about allocation of resources to deliver care for transplant patients who might otherwise have excellent 1-year and 10-year survival rates. Children and young adults with end-stage organ disease in particular seem more disadvantaged by withholding transplantation because of capacity issues than from medical consequences of SARS-CoV-2. This report details the nationwide response of the Dutch transplant community to these issues and the immediate consequences for transplant activity. Worrisome, there was a significant decrease in organ donation numbers affecting all organ transplant services. In addition, there was a detrimental effect on transplantation numbers in children with end-organ failure. Ongoing efforts focus on mitigation of not only primary but also secondary harm of the pandemic and to find right definitions and momentum to restore the transplant programs.","Transpl Immunol","de Vries, A P J","Alwayn, I P J","Hoek, R A S","van den Berg, A P","Ultee, F C W","Vogelaar, S M","Haase-Kromwijk, B J J M","Heemskerk, M B A","Hemke, A C","Nijboer, W N","Schaefer, B S","Kuiper, M A","de Jonge, J","van der Kaaij, N P","Reinders, M E J","32371150"],"abstract":["The rapid emergence of the COVID-19 pandemic is unprecedented and poses an unparalleled obstacle in the sixty-five year history of organ transplantation. Worldwide, the delivery of transplant care is severely challenged by matters concerning - but not limited to - organ procurement, risk of SARS-CoV-2 transmission, screening strategies of donors and recipients, decisions to postpone or proceed with transplantation, the attributable risk of immunosuppression for COVID-19 and entrenched health care resources and capacity. The transplant community is faced with choosing a lesser of two evils: initiating immunosuppression and potentially accepting detrimental outcome when transplant recipients develop COVID-19 versus postponing transplantation and accepting associated waitlist mortality. Notably, prioritization of health care services for COVID-19 care raises concerns about allocation of resources to deliver care for transplant patients who might otherwise have excellent 1-year and 10-year survival rates. Children and young adults with end-stage organ disease in particular seem more disadvantaged by withholding transplantation because of capacity issues than from medical consequences of SARS-CoV-2. This report details the nationwide response of the Dutch transplant community to these issues and the immediate consequences for transplant activity. Worrisome, there was a significant decrease in organ donation numbers affecting all organ transplant services. In addition, there was a detrimental effect on transplantation numbers in children with end-organ failure. Ongoing efforts focus on mitigation of not only primary but also secondary harm of the pandemic and to find right definitions and momentum to restore the transplant programs."],"journal":"Transpl Immunol","authors":["de Vries, A P J","Alwayn, I P J","Hoek, R A S","van den Berg, A P","Ultee, F C W","Vogelaar, S M","Haase-Kromwijk, B J J M","Heemskerk, M B A","Hemke, A C","Nijboer, W N","Schaefer, B S","Kuiper, M A","de Jonge, J","van der Kaaij, N P","Reinders, M E J"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371150","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.trim.2020.101304","keywords":["covid-19","outbreak","sars-cov-2","transplant programs","transplantation"],"locations":["Dutch","Netherlands"],"countries":["Netherlands"],"countries_codes":["NLD|Netherlands"],"topics":["Prevention"],"weight":1,"_version_":1666138496449904640,"score":270.84695},{"pmid":32400013,"title":"A case of coronavirus disease 2019-infected liver transplant donor.","text":["A case of coronavirus disease 2019-infected liver transplant donor.","Coronavirus disease 2019 (COVID-19) is a novel infectious disease that continues to spread on a global scale. There has been growing concern about donor-derived transmissions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, we present the case of a patient who underwent ABO-incompatible living donor liver transplantation without knowing that the liver donor was infected with COVID-19 during the donation procedure. In this case, the donor-derived transmission to the recipient was not identified, and the liver donor was found to be recovering from a COVID-19 infection. The donor-derived transmission was not identified.","Am J Transplant","Hong, Hyo-Lim","Kim, Sung-Han","Choi, Dong Lak","Kwon, Hyun Hee","32400013"],"abstract":["Coronavirus disease 2019 (COVID-19) is a novel infectious disease that continues to spread on a global scale. There has been growing concern about donor-derived transmissions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, we present the case of a patient who underwent ABO-incompatible living donor liver transplantation without knowing that the liver donor was infected with COVID-19 during the donation procedure. In this case, the donor-derived transmission to the recipient was not identified, and the liver donor was found to be recovering from a COVID-19 infection. The donor-derived transmission was not identified."],"journal":"Am J Transplant","authors":["Hong, Hyo-Lim","Kim, Sung-Han","Choi, Dong Lak","Kwon, Hyun Hee"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32400013","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/ajt.15997","keywords":["covid-19","liver transplantation"],"topics":["Case Report"],"weight":1,"_version_":1666865855040847872,"score":268.86288},{"pmid":32368850,"title":"Utilization of deceased donors during a pandemic: An argument against using SARS-CoV-2 positive donors.","text":["Utilization of deceased donors during a pandemic: An argument against using SARS-CoV-2 positive donors.","SARS-CoV-2 has rapidly become an unprecedented pandemic that has impacted society, disrupted hospital functions, strained healthcare resources and impacted the lives of transplant professionals. Despite this, organ failure and the need for transplantation continues throughout the United States. Considering the perpetual scarcity of deceased donor organs, Kates et al present a viewpoint that advocates for the utilization of COVID-19 positive donors in selected cases. We present a review of the current literature that details the potential negative consequences of COVID-19 positive donors. The factors we consider include: 1) the risk of blood transmission SARS-CoV-2, 2) involvement of donor organs, 3) lack of effective therapies, 4) exposure of healthcare and recovery teams, 5) disease transmission and propagation, and 6) hospital resource utilization. While we acknowledge that transplantation fulfills the mission of saving lives, it is imperative to consider the consequences not only to our recipients, but also to the community and to healthcare workers, particularly in the absence of effective preventative or curative therapies. For these reasons, we believe the evidence and risks show that COVID-19 infection should continue to remain a contraindication for donation, as has been the initial response of donation and transplantation societies.","Am J Transplant","Shah, Malay B","Lynch, Raymond J","El-Haddad, Hanine","Doby, Brianna","Brockmeier, Diane","Goldberg, David S","32368850"],"abstract":["SARS-CoV-2 has rapidly become an unprecedented pandemic that has impacted society, disrupted hospital functions, strained healthcare resources and impacted the lives of transplant professionals. Despite this, organ failure and the need for transplantation continues throughout the United States. Considering the perpetual scarcity of deceased donor organs, Kates et al present a viewpoint that advocates for the utilization of COVID-19 positive donors in selected cases. We present a review of the current literature that details the potential negative consequences of COVID-19 positive donors. The factors we consider include: 1) the risk of blood transmission SARS-CoV-2, 2) involvement of donor organs, 3) lack of effective therapies, 4) exposure of healthcare and recovery teams, 5) disease transmission and propagation, and 6) hospital resource utilization. While we acknowledge that transplantation fulfills the mission of saving lives, it is imperative to consider the consequences not only to our recipients, but also to the community and to healthcare workers, particularly in the absence of effective preventative or curative therapies. For these reasons, we believe the evidence and risks show that COVID-19 infection should continue to remain a contraindication for donation, as has been the initial response of donation and transplantation societies."],"journal":"Am J Transplant","authors":["Shah, Malay B","Lynch, Raymond J","El-Haddad, Hanine","Doby, Brianna","Brockmeier, Diane","Goldberg, David S"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32368850","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/ajt.15969","locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138496232849409,"score":268.85077}]}